HIV Citation List: December 9, 2011 - December 22, 2011
Pubmed citations
1. Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral Antagonism. Arias, J.F., Y. Iwabu, and K. Tokunaga, Frontiers in Microbiology, 2011. 2: p. 250; PMID[22180752].
[PubMed]. HIV_1209-122211.
2. Synthesis of the Pyridinyl Analogues of Dibenzylideneacetone (pyr-dba) via an Improved Claisen-Schmidt Condensation, Displaying Diverse Biological Activities as Curcumin Analogues. Cao, B., Y. Wang, K. Ding, N. Neamati, and Y.Q. Long, Organic & Biomolecular Chemistry, 2011. [Epub ahead of print]; PMID[22179573].
[PubMed]. HIV_1209-122211.
3. Synthesis, Structure-Activity Relationships, and Mechanism of Action of anti-HIV-1 Lamellarin alpha 20-sulfate Analogues. Kamiyama, H., Y. Kubo, H. Sato, N. Yamamoto, T. Fukuda, F. Ishibashi, and M. Iwao, Bioorganic & Medicinal Chemistry, 2011. 19(24): p. 7541-7550; PMID[22071527].
[PubMed]. HIV_1209-122211.
4. Ribosome Inactivating Proteins from Plants Inhibiting Viruses. Kaur, I., R.C. Gupta, and M. Puri, Virologica Sinica, 2011. 26(6): p. 357-365; PMID[22160935].
[PubMed]. HIV_1209-122211.
5. Synthesis and Anti-HIV Activity of Aryl-2-[(4-cyanophenyl)amino]-4-pyrimidinone hydrazones as Potent Non-nucleoside Reverse Transcriptase Inhibitors. Ma, X.D., S.Q. Yang, S.X. Gu, Q.Q. He, F.E. Chen, E. De Clercq, J. Balzarini, and C. Pannecouque, ChemMedChem, 2011. 6(12): p. 2225-2232; PMID[21990112].
[PubMed]. HIV_1209-122211.
6. Interfacial Inhibitors: Targeting Macromolecular Complexes. Pommier, Y. and C. Marchand, Nature Reviews. Drug Discovery, 2011. [Epub ahead of print]; PMID[22173432].
[PubMed]. HIV_1209-122211.
7. Surface Modified Nevirapine Nanosuspensions for Viral Reservoir Targeting: In Vitro and in Vivo Evaluation. Shegokar, R. and K.K. Singh, International Journal of Pharmaceutics, 2011. 421(2): p. 341-352; PMID[21986114].
[PubMed]. HIV_1209-122211.
8. The Mechanism of Interaction of Human Mitochondrial DNA Polymerase gamma with the Novel Nucleoside Reverse Transcriptase Inhibitor 4' -Ethynyl-2-fluoro-2' -deoxyadenosine Indicates a Low Potential for Host Toxicity. Sohl, C.D., K. Singh, R. Kasiviswanathan, W.C. Copeland, H. Mitsuya, S.G. Sarafianos, and K.S. Anderson, Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[22155823].
[PubMed]. HIV_1209-122211.
9. Rapid Development of Glycan-specific, Broad, and Potent anti-HIV-1 gp120 Neutralizing Antibodies in an R5 SIV/HIV Chimeric Virus Infected Macaque. Walker, L.M., D. Sok, Y. Nishimura, O. Donau, R. Sadjadpour, R. Gautam, M. Shingai, R. Pejchal, A. Ramos, M.D. Simek, Y. Geng, I.A. Wilson, P. Poignard, M.A. Martin, and D.R. Burton, Proceedings of the National Academy of Sciences of the United States of America 2011. 108(50): p. 20125-20129; PMID[22123961].
[PubMed]. HIV_1209-122211.
10. Potent Activity of a Nucleoside Reverse Transcriptase Inhibitor, 4'-Ethynyl-2-fluoro-2'-deoxyadenosine, against Human Immunodeficiency Virus Type 1 Infection in a Model Using Human Peripheral Blood Mononuclear Cell-transplanted NOD/SCID Janus Kinase 3 knockout Mice. Hattori, S., K. Ide, H. Nakata, H. Harada, S. Suzu, N. Ashida, S. Kohgo, H. Hayakawa, H. Mitsuya, and S. Okada, Antimicrobial Agents and Chemotherapy, 2009. 53(9): p. 3887-3893; PMID[19546363].
[PubMed]. HIV_1209-122211.
ISI Web of Knowledge citations
11. Synthesis and Transformations of Novel Formyl-substituted Quinolines. Aleksanyan, I.S., K Panosyan, H, Heterocyclic Communications, 2011. 17(3-4): p. 105-110; ISI[000297136200003].
[WOS]. HIV_1209-122211.
12. Anti-HIV Activity of Natural Triterpenoids and Hemisynthetic Derivatives 2004-2009. Cassels, B.K. and M. Asencio, Phytochemistry Reviews, 2011. 10(4): p. 545-564; ISI[000297151800007].
[WOS]. HIV_1209-122211.
13. Silver Nanoparticles as Potential Antiviral Agents. Galdiero, S.F., A Vitiello, M Cantisani, M Marra, V Galdiero, M, Molecules, 2011. 16(10): p. 8894-8918; ISI[000296973000051].
[WOS]. HIV_1209-122211.
14. Advances in the Synthesis and Pharmacological Activity of Lupane-type Triterpenoid Saponins.
Gauthier, C., J. Legault, M. Piochon-Gauthier, and A. Pichette, Phytochemistry Reviews, 2011. 10(4): p. 521-544; ISI[000297151800006].
[WOS]. HIV_1209-122211.
15. Investigation of Furo[2,3-h]- and Pyridazino[3,4-f]cinnolin-3-ol Scaffolds as Substrates for the Development of Novel HIV-1 Integrase Inhibitors. Gomaa, M.F.Y., N. Pala, M. Derudas, J.A. Hasanen, E.H. El-Tamany, P. Casule, A. Mariani, and M. Sechi, Arkivoc, 2011: p. 1-14; ISI[000296852800001].
[WOS]. HIV_1209-122211.
16. Design and Synthesis of Pyridone Inhibitors of Non-Nucleoside Reverse Transcriptase. Gomez, R., S. Jolly, T. Williams, T. Tucker, R. Tynebor, J. Vacca, G. McGaughey, M.T. Lai, P. Felock, V. Munshi, D. DeStefano, S. Touch, M. Miller, Y.W. Yan, R. Sanchez, Y.X. Liang, B. Paton, B.L. Wan, and N. Anthony, Bioorganic & Medicinal Chemistry Letters 2011. 21(24): p. 7344-7350; ISI[000297150600021].
[WOS]. HIV_1209-122211.
17. Characterization of a Novel Type of HIV-1 Particle Assembly Inhibitor Using a Quantitative Luciferase-Vpr Packaging-Based Assay. Gonzalez, G.D., S Errazuriz, E Coric, P Souquet, F Turcaud, S Boulanger, P Bouaziz, S Hong, SS, Plos One, 2011. 6(11); ISI[000297197000035].
[WOS]. HIV_1209-122211.
18. Effects of Antiretroviral Protease Inhibitors, Lopinavir and Ritonavir, on the Hepatobiliary Disposition of Bile Acids in Sandwich-cultured Rat Hepatocytes. Griffin, L.M. and K.L.R. Brouwer, Drug Metabolism Reviews, 2011. 43: p. 197-197; ISI[000297056400373].
[WOS]. HIV_1209-122211.
19. Evaluation of a Fluorescent Derivative of AMD3100 and Its Interaction with the CXCR4 Chemokine Receptor. Knight, J.C., A.J. Hallett, A. Brancale, S.J. Paisey, R.W.E. Clarkson, and P.G. Edwards, ChemBioChem, 2011. 12(17): p. 2692-2698; ISI[000297160500026].
[WOS]. HIV_1209-122211.
20. Regioselective Synthesis of Novel 3-Thiazolidine Acetic Acid Derivatives from Glycosido Ureides. Li, Y.X., W. Chen, X.P. Yang, G.P. Yu, M.Z. Mao, Y.Y. Zhou, T.W. Liu, and Z.M. Li, Chemical Biology & Drug Design, 2011. 78(6): p. 969-978; ISI[000297095000009].
[WOS]. HIV_1209-122211.
21. Synthesis of Linear Dibenzo[1,8]naphthyridines using 2-chloro-4-methylquinolines. Manoj, M. and K.J.R. Prasad, Arkivoc. 2011: p. 289-307; ISI[000296852800022].
[WOS]. HIV_1209-122211.
22. Advances in HIV Microbicide Development. Olsen, J.E., D Dewhurst, S, Future Medicinal Chemistry, 2011. 3(16): p. 2101-2116; ISI[000297161800016].
[WOS]. HIV_1209-122211.
23. Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site. Rhodes, D.P., TS Vandegraaff, N Jeevarajah, D Newman, J Martyn, J Coates, JAV Ede, NJ Rea, P Deadman, JJ, ChemBioChem, 2011. 12(15): p. 2311-2315; ISI[000296859900013].
[WOS]. HIV_1209-122211.
24. Anti-HIV-1 Reverse Transcriptase Activities of Hexane Extracts from some Asian Medicinal Plants. Silprasit, K., S. Seetaha, P. Pongsanarakul, S. Hannongbua, and K. Choowongkomon, Journal of Medicinal Plants Research, 2011. 5(17): p. 4194-4201; ISI[000297465300028].
[WOS]. HIV_1209-122211.
25. Effects of New Quinizarin Derivatives on both HCV NS5B RNA Polymerase and HIV-1 Reverse Transcriptase Associated Ribonuclease H Activities. Tramontano, E.K., T Zinzula, L Esposito, F, Journal of Chemotherapy, 2011. 23(5): p. 273-276; ISI[000297189900004].
[WOS]. HIV_1209-122211.
26. Syntheses of Indolo[3,2,1-d,e]phenanthridines and Isochromeno[3,4-a] carbazoles: Palladium Catalyzed Intramolecular Arylation via C-H Functionalization. Yamuna, E., M. Zeller, and K.J.R. Prasad, Tetrahedron Letters 2011. 52(45): p. 6030-6034; ISI[000296548400033].
[WOS]. HIV_1209-122211.